# Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life

> **NCT06136962** · — · UNKNOWN · sponsor: **Fujian Cancer Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06136962
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06136962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06136962, "Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06136962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*